UB Paderborn / Katalog / Suche / in CDI

Hepatitis C virus infection and the role of a pharmaceutical care program

American journal of health-system pharmacy, 2020-03, Vol.77 (6), p.479-486

2020

Link zum Volltext

Verfügbarkeit prüfen

Tratamiento de la vaginitis refractaria por Candida krusei con anfotericina B tópica

Medicina clínica, 2016-12, Vol.147 (12), p.565-566

2016

Link zum Volltext

Verfügbarkeit prüfen

CP-163 Onco-haematological outpatients treated with oral antineoplastic agents: pharmacist interventions

European journal of hospital pharmacy. Science and practice, 2017-03, Vol.24 (Suppl 1), p.A73-A73

2017

Link zum Volltext

Verfügbarkeit prüfen

DI-054 Safety results of direct acting antivirals for the treatment of hepatitis C virus infection

European journal of hospital pharmacy. Science and practice, 2016-03, Vol.23 (Suppl 1), p.A141-A141

2016

Link zum Volltext

Verfügbarkeit prüfen

CP-212 Effectiveness and safety of new direct acting antivirals for the treatment of hepatitis C infection: Preliminary data in a coinfected HIV/HCV population

European journal of hospital pharmacy. Science and practice, 2016-03, Vol.23 (Suppl 1), p.A93-A94

2016

Link zum Volltext

Verfügbarkeit prüfen

CP-119 Questions about the new direct acting antiviral agents

European journal of hospital pharmacy. Science and practice, 2016-03, Vol.23 (Suppl 1), p.A52-A52

2016

Link zum Volltext

Verfügbarkeit prüfen

Assessment of new drugs in a tertiary hospital using a standardized tool

Farmacia Hospitalaria, 2013-10, Vol.37 (5), p.388-393

2013

Link zum Volltext

Verfügbarkeit prüfen

P646 Clinical decision support in the prevention of adverse effects associated with immunosuppressive drugs in patients with Inflammatory Bowel Disease

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i1233-i1233

2024

Link zum Volltext

Verfügbarkeit prüfen

5PSQ-119 A new pharmaceutical care programme for COVID-19 patients treated with Paxlovid®: Implementation and safety outcomes reported

European journal of hospital pharmacy. Science and practice, 2023-03, Vol.30 (Suppl 1), p.A151-A152

2023

Link zum Volltext

Verfügbarkeit prüfen

4CPS-045 Healthcare evaluation of hospital pharmacy services by patients with immune-mediated inflammatory diseases: a multicentre study

European journal of hospital pharmacy. Science and practice, 2022-03, Vol.29 (Suppl 1), p.A43-A43

2022

Link zum Volltext

Verfügbarkeit prüfen

4CPS-329 Do patients with immune mediated inflammatory diseases think they know their medication?

European journal of hospital pharmacy. Science and practice, 2021-03, Vol.28 (Suppl 1), p.A79-A79

2021

Link zum Volltext

Verfügbarkeit prüfen

5PSQ-134 Analysis of factors related to the clinical course of COVID-19 infection in patients with hypertension

European journal of hospital pharmacy. Science and practice, 2021-03, Vol.28 (Suppl 1), p.A123-A123

2021

Link zum Volltext

Verfügbarkeit prüfen

4CPS-238 Evaluation of effectiveness of compounded oral vancomycin capsules for treatment of Clostridium difficile infection

European journal of hospital pharmacy. Science and practice, 2021-03, Vol.28 (Suppl 1), p.A34-A34

2021

Link zum Volltext

Verfügbarkeit prüfen

5PSQ-033 Effectiveness of computerised decision support system-based intervention in antimicrobial use: the HIGEA project

European journal of hospital pharmacy. Science and practice, 2019-03, Vol.26 (Suppl 1), p.A216-A217

2019

Link zum Volltext

Verfügbarkeit prüfen

6ER-007 Off-label use of dalbavancin in gram-positive infections: effectiveness, safety and cost in clinical practice

European journal of hospital pharmacy. Science and practice, 2019-03, Vol.26 (Suppl 1), p.A280-A281

2019

Link zum Volltext

Verfügbarkeit prüfen

4CPS-053 Study on daptomycin use as a first step towards an antimicrobial stewardship programme

European journal of hospital pharmacy. Science and practice, 2019-03, Vol.26 (Suppl 1), p.A92-A92

2019

Link zum Volltext

Verfügbarkeit prüfen

CP-115 Second generation direct acting antiviral agents in post-transplant hepatitis c virus infection recurrence: Real clinical practice

European journal of hospital pharmacy. Science and practice, 2016-03, Vol.23 (Suppl 1), p.A50-A51

2016

Link zum Volltext

Verfügbarkeit prüfen

CP-096 Final results of effectiveness and safety of direct acting antiviral agents in the treatment of chronic hepatitis c virus infection

European journal of hospital pharmacy. Science and practice, 2016-03, Vol.23 (Suppl 1), p.A42-A42

2016

Link zum Volltext

Verfügbarkeit prüfen

Assessment of new drugs in a tertiary hospital using a standardized tool

Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, 2013-09, Vol.37 (5), p.388

2013

Link zum Volltext

Verfügbarkeit prüfen

Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial

The Lancet (British edition), 2011-06, Vol.377 (9782), p.2013-2022

2011

Link zum Volltext

Verfügbarkeit prüfen

Chemoprotective effect of Spirulina ( Arthrospira) against cyclophosphamide-induced mutagenicity in mice

Food and chemical toxicology, 2008-02, Vol.46 (2), p.567-574

2008

Link zum Volltext

Verfügbarkeit prüfen

Improving pharmacotherapy outcomes in patients with hepatitis C virus infection treated with direct‐acting antivirals: The GRUviC project

International journal of clinical practice (Esher), 2017-08, Vol.71 (8), p.e12988-n/a

2017

Link zum Volltext

Verfügbarkeit prüfen

Rationale and Design of a Randomized, Double-Blind, Parallel-Group Study of Terutroban 30 mg/day versus Aspirin 100 mg/day in Stroke Patients: The Prevention of Cerebrovascular and Cardiovascular Events of Ischemic Origin with Terutroban in Patients with a History of Ischemic Stroke or Transient Ischemic Attack (PERFORM) Study

Cerebrovascular diseases (Basel, Switzerland), 2009-01, Vol.27 (5), p.509-518

2009

Link zum Volltext

Verfügbarkeit prüfen

Neurocognitive diagnosis and cut-off scores of the Screen for Cognitive Impairment in Psychiatry (SCIP-S)

Schizophrenia research, 2010-02, Vol.116 (2), p.243-251

2010

Link zum Volltext

Verfügbarkeit prüfen

Delimitación automática de ceniza volcánica en imágenes satelitales mediante Deep Learning

FIGEMPA, 2022-01, Vol.13 (1), p.48-58

2022

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Hepatitis C virus infection and the role of a pharmaceutical care program

Tratamiento de la vaginitis refractaria por Candida krusei con anfotericina B tópica

CP-163 Onco-haematological outpatients treated with oral antineoplastic agents: pharmacist interventions

DI-054 Safety results of direct acting antivirals for the treatment of hepatitis C virus infection

CP-212 Effectiveness and safety of new direct acting antivirals for the treatment of hepatitis C infection: Preliminary data in a coinfected HIV/HCV population

CP-119 Questions about the new direct acting antiviral agents

Assessment of new drugs in a tertiary hospital using a standardized tool

P646 Clinical decision support in the prevention of adverse effects associated with immunosuppressive drugs in patients with Inflammatory Bowel Disease

5PSQ-119 A new pharmaceutical care programme for COVID-19 patients treated with Paxlovid®: Implementation and safety outcomes reported

4CPS-045 Healthcare evaluation of hospital pharmacy services by patients with immune-mediated inflammatory diseases: a multicentre study

4CPS-329 Do patients with immune mediated inflammatory diseases think they know their medication?

5PSQ-134 Analysis of factors related to the clinical course of COVID-19 infection in patients with hypertension

4CPS-238 Evaluation of effectiveness of compounded oral vancomycin capsules for treatment of Clostridium difficile infection

5PSQ-033 Effectiveness of computerised decision support system-based intervention in antimicrobial use: the HIGEA project

6ER-007 Off-label use of dalbavancin in gram-positive infections: effectiveness, safety and cost in clinical practice

4CPS-053 Study on daptomycin use as a first step towards an antimicrobial stewardship programme

CP-115 Second generation direct acting antiviral agents in post-transplant hepatitis c virus infection recurrence: Real clinical practice

CP-096 Final results of effectiveness and safety of direct acting antiviral agents in the treatment of chronic hepatitis c virus infection

Assessment of new drugs in a tertiary hospital using a standardized tool

Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial

Chemoprotective effect of Spirulina ( Arthrospira) against cyclophosphamide-induced mutagenicity in mice

Improving pharmacotherapy outcomes in patients with hepatitis C virus infection treated with direct‐acting antivirals: The GRUviC project

Neurocognitive diagnosis and cut-off scores of the Screen for Cognitive Impairment in Psychiatry (SCIP-S)

Delimitación automática de ceniza volcánica en imágenes satelitales mediante Deep Learning

Suchergebnisse filtern